BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 113476
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113476
Table 1 Basic information of patients, n (%)/mean ± SD

Control group
Adenoma group
t/χ2
P value
Number103315
Gender
    Male55 (53.4)202 (64.1)3.7730.052
    Female48 (46.6)113 (35.9)
Age (years)52.70 ± 14.3554.97 ± 12.74-1.5250.128
History of diabetes16 (15.5)97 (30.8)9.1630.002
History of hypertension19 (18.4)66 (21.0)0.3010.583
Hyperuricemia1 (1.0)6 (1.9)0.0400.842
Hyperlipidemia5 (4.9)24 (7.6)0.9190.338
Table 2 Univariate logistic regression analysis

B
SE
Wald
OR
95%CI
P value
Gender0.4450.2303.7451.5600.994-2.4480.053
Age (years)0.0130.0092.3091.0130.996-1.030.129
History of diabetes0.8840.2988.7822.4191.349-4.340.003
History of hypertension0.1590.2890.3001.1720.665-2.0660.584
Hyperuricemia0.6831.0860.3961.9810.236-16.6460.529
Hyperlipidemia0.4800.5050.9031.6160.6-4.3520.342
Table 3 Multivariate logistic regression analysis

B
SE
Wald
OR
95%CI
P value
Gender0.4460.2343.6371.5620.988-2.4710.057
Age (years)0.0110.0091.4981.0110.994-1.0280.221
History of diabetes0.8170.3027.3122.2631.252-4.090.007
Table 4 Analysis of carcinoembryonic antigen and insulin-like growth factor-1 levels in each experimental group, median (interquartile rage)/mean ± SD

A + D group (n = 20)
A + ND group (n = 20)
NA + ND group (n = 10)
CEA (ng/mL)3.63 (2.46-4.85)2.19 (1.35-2.98)a1.41 (0.90-2.11)a
IGF-1 (ng/mL)142.53 ± 16.38123.70 ± 11.32b102.52 ± 8.98b
Table 5 Average optical value analysis of each experimental group, mean ± SD
AO
A + D group (n = 20)
A + ND group (n = 20)
NA + ND group (n = 20)
β-catenin0.118 ± 0.0270.094 ± 0.028a0.045 ± 0.02a
TCF7 L20.063 ± 0.0290.030 ± 0.012b0.023 ± 0.010b
Ki670.078 ± 0.0280.038 ± 0.014c0.018 ± 0.014c